Vega Investment Solutions Makes New $1.88 Million Investment in Cencora, Inc. (NYSE:COR)

Vega Investment Solutions acquired a new position in shares of Cencora, Inc. (NYSE:COR - Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 8,345 shares of the company's stock, valued at approximately $1,875,000. Cencora makes up 1.5% of Vega Investment Solutions' portfolio, making the stock its 15th largest holding.

Other hedge funds also recently added to or reduced their stakes in the company. JFS Wealth Advisors LLC grew its holdings in Cencora by 63.0% during the 4th quarter. JFS Wealth Advisors LLC now owns 119 shares of the company's stock worth $27,000 after acquiring an additional 46 shares in the last quarter. Banque Transatlantique SA acquired a new position in Cencora during the 4th quarter worth $29,000. SBI Securities Co. Ltd. acquired a new position in Cencora during the 4th quarter worth $30,000. Kentucky Trust Co acquired a new position in Cencora during the 4th quarter worth $33,000. Finally, WASHINGTON TRUST Co grew its holdings in Cencora by 37.7% during the 4th quarter. WASHINGTON TRUST Co now owns 168 shares of the company's stock worth $38,000 after acquiring an additional 46 shares in the last quarter. 97.52% of the stock is owned by institutional investors and hedge funds.

Cencora Trading Down 0.5%

Cencora stock opened at $290.03 on Friday. The company has a quick ratio of 0.54, a current ratio of 0.92 and a debt-to-equity ratio of 16.40. The firm has a 50-day moving average price of $281.86 and a two-hundred day moving average price of $256.65. The firm has a market capitalization of $56.21 billion, a price-to-earnings ratio of 41.26, a PEG ratio of 1.31 and a beta of 0.60. Cencora, Inc. has a 52-week low of $214.77 and a 52-week high of $309.35.

Cencora (NYSE:COR - Get Free Report) last posted its earnings results on Wednesday, May 7th. The company reported $4.42 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $4.07 by $0.35. The firm had revenue of $75.50 billion during the quarter, compared to analyst estimates of $75.41 billion. Cencora had a net margin of 0.46% and a return on equity of 328.62%. Cencora's revenue was up 10.3% on a year-over-year basis. During the same period in the previous year, the business posted $3.80 EPS. Sell-side analysts expect that Cencora, Inc. will post 15.37 earnings per share for the current year.

Cencora Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Monday, June 2nd. Shareholders of record on Friday, May 16th will be given a dividend of $0.55 per share. The ex-dividend date is Friday, May 16th. This represents a $2.20 dividend on an annualized basis and a dividend yield of 0.76%. Cencora's dividend payout ratio (DPR) is 25.52%.

Insiders Place Their Bets

In other Cencora news, Chairman Steven H. Collis sold 14,578 shares of the business's stock in a transaction dated Tuesday, March 25th. The shares were sold at an average price of $269.51, for a total transaction of $3,928,916.78. Following the sale, the chairman now directly owns 317,913 shares in the company, valued at approximately $85,680,732.63. The trade was a 4.38% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Robert P. Mauch sold 4,969 shares of the business's stock in a transaction dated Monday, April 21st. The stock was sold at an average price of $289.33, for a total transaction of $1,437,680.77. Following the sale, the chief executive officer now owns 47,582 shares in the company, valued at $13,766,900.06. This trade represents a 9.46% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 45,223 shares of company stock worth $12,369,767. 10.80% of the stock is owned by corporate insiders.

Wall Street Analyst Weigh In

COR has been the subject of several research reports. Citigroup lifted their price target on shares of Cencora from $330.00 to $355.00 and gave the company a "buy" rating in a report on Thursday, May 8th. Wells Fargo & Company lifted their price target on shares of Cencora from $251.00 to $274.00 and gave the company an "equal weight" rating in a report on Friday, March 14th. Morgan Stanley set a $288.00 price target on shares of Cencora in a report on Tuesday, April 15th. Bank of America lifted their price target on shares of Cencora from $270.00 to $285.00 and gave the company a "neutral" rating in a report on Friday, April 11th. Finally, Evercore ISI lifted their price target on shares of Cencora from $270.00 to $280.00 and gave the company an "outperform" rating in a report on Thursday, February 6th. Two analysts have rated the stock with a hold rating and nine have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and a consensus price target of $301.18.

About Cencora

Cencora, Inc sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.